Literature DB >> 6370703

Increase in plasma free fatty acids and natriuresis by xanthines may reflect adenosine antagonism.

K E Andersson, N Johannesson, B Karlberg, C G Persson.   

Abstract

The hypothesis has been examined that adenosine is involved in the diuretic and free fatty acid (FFA) - releasing action of xanthines. The effects of theophylline (T), a potent adenosine antagonist, were compared with those of enprofylline (3-propyl xanthine, E), which exerts negligible antagonism of adenosine. Eight healthy male volunteers were given E 1.5 mg/kg, T 5.0 mg/kg or placebo 0.9% saline (P) intravenously in a double-blind, randomized, cross-over investigation. Blood samples were analyzed for E, T, catecholamines (CA: adrenaline, noradrenaline and dopamine), FFA, renin, glucose, glucagon and insulin, and urine was collected at 2-h intervals. T (plasma concentration 53 +/- 8 mumol/l) but not E (11 +/- 2 mumol/l) caused an increase in FFA from 0.42 to 0.86 mmol/l after 90 min. Without affecting the urinary excretion of potassium, T doubled natriuresis and the urine volume as compared to E and P. Neither T nor E had any effect on plasma CA, or on any other of the metabolic parameters studied. E, but not T, produced a small but statistically significant decrease in diastolic blood pressure (5 mmHg) and an increase in heart rate (3 beats/min). It is suggested that the difference between E and T in terms of stimulation of FFA-release and natriuresis may be related to their different ability to antagonize adenosine.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6370703     DOI: 10.1007/bf00546705

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  36 in total

Review 1.  Metabolic response during impending myocardial infarction. II. Clinical implications.

Authors:  M F Oliver
Journal:  Circulation       Date:  1972-02       Impact factor: 29.690

Review 2.  Modulation of neurotransmission by purine nucleotides and nucleosides.

Authors:  B B Fredholm; P Hedqvist
Journal:  Biochem Pharmacol       Date:  1980-06-15       Impact factor: 5.858

Review 3.  Extrapulmonary effects of theophylline.

Authors:  K E Andersson; C G Persson
Journal:  Eur J Respir Dis Suppl       Date:  1980

4.  Increase in lipolysis and decrease in plasma-heparin lipoprotein lipase activity and alpha 1 lipoprotein level after aminophylline in man.

Authors:  L Zanaboni; D Bonfiglioli; D Sommariva; D D'Adda; A Fasoli
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

5.  Adenosine as a possible mediator of metabolic control of glomerular filtration rate.

Authors:  H Osswald; G Nabakowski; H Hermes
Journal:  Int J Biochem       Date:  1980

6.  Xanthine derivatives as adenosine receptor antagonists.

Authors:  B B Fredholm; C G Persson
Journal:  Eur J Pharmacol       Date:  1982-07-30       Impact factor: 4.432

7.  Positive inotropic and chronotropic effects and coronary vasodilation in vitro by two antiasthmatic xanthines with different abilities to antagonize adenosine.

Authors:  C G Persson; I Erjefält; K E Andersson
Journal:  J Cardiovasc Pharmacol       Date:  1983 Sep-Oct       Impact factor: 3.105

8.  Caffeine: its effect on catecholamines and metabolism in lean and obese humans.

Authors:  R T Jung; P S Shetty; W P James; M A Barrand; B A Callingham
Journal:  Clin Sci (Lond)       Date:  1981-05       Impact factor: 6.124

9.  Stimulation of release of adrenal catecholamine by adenosine 3':5'-cyclic monophosphate and theophylline in the absence of extracellular Ca 2+ .

Authors:  M J Peach
Journal:  Proc Natl Acad Sci U S A       Date:  1972-04       Impact factor: 11.205

10.  Seizure activity in animals given enprofylline and theophylline, two xanthines with partly different mechanisms of action.

Authors:  C G Persson; I Erjefält
Journal:  Arch Int Pharmacodyn Ther       Date:  1982-08
View more
  5 in total

1.  Cardiovascular effects of two different xanthines in healthy subjects. Studies at rest, during exercise and in combination with a beta-agonist, terbutaline.

Authors:  T B Conradson
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 2.  Methylxanthines and the kidney.

Authors:  Hartmut Osswald; Jürgen Schnermann
Journal:  Handb Exp Pharmacol       Date:  2011

3.  The diuretic action of 8-cyclopentyl-1,3-dipropylxanthine, a selective A1 adenosine receptor antagonist.

Authors:  R J Knight; C J Bowmer; M S Yates
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

4.  Maximally effective plasma concentrations of enprofylline and theophylline during constant infusion.

Authors:  L C Laursen; N Johannesson; I Søndergaard; B Weeke
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

5.  Additive renal effects of indomethacin and dipyridamole in man.

Authors:  P Seideman; A Sollevi; B B Fredholm
Journal:  Br J Clin Pharmacol       Date:  1987-03       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.